Edward Erickson has been elected as president and CEO of BioNanomatrix by the company's board of directors. Erickson, who was executive chairman of the board, succeeds Michael Boyce-Jacino, who has stepped down as president and CEO and from the board. Tracy Warren, a general partner at Battelle Ventures, an investor in BioNanomatrix, will become chair of the board.
Most recently, Erickson was a consultant to companies and venture capital firms. In the past, he was president, CEO, or a director of more than a dozen life-science-based companies, several of which completed IPOs under his leadership. He is currently a director at Metabolon and at Molecular Biometrics. Erickson holds an MBA in general management from Harvard Business School and MS and BS degrees in mathematics from the Illinois Institute of Technology.